Publication | Closed Access

Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial

UrologyOncologyGenitourinary CancerMedicineImmune Checkpoint InhibitorPharmacotherapyDose-expansion Phase 1BCancer TreatmentPharmacologyRenal Pharmacology